Single-center experience demonstrates effective outcomes of allogeneic stem cell transplantation in relapsed Hodgkin lymphoma, suggesting a feasible treatment option.
In Indian patients with chemotherapy-sensitive relapsed HL, allo-HSCT using reduced-intensity and reduced toxicity conditioning regimens and post-transplant cyclophosphamide-based regimens has proven feasible and effective, yielding encouraging survival outcomes within routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Wadhera et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: